Laboratory Products
Reporter Lentivirus for Signalling Pathway Studies
Jun 07 2018
Amsbio provides a range of ready-to-use Reporter Lentivirus for assessing cell signalling activities in virtually any mammalian cell type.
These pre-made products use a unique combination of transcription factor reporter technology coupled with lentiviral delivery to provide a simple, highly sensitive method capable of operating over a large dynamic range.
By measuring the activities of a reporter, Amsbio Reporter Lentivirus can be used for performing gene regulation studies in living mammalian cells and for functional genomics as well as drug screening cell signallling assays. In addition Reporter Lentivirus can be used for generating your own pathway screening assay cell lines for the cell based assay in your desired cell types.
Amsbio offers a wide range of ‘signalling pathway lentiviruses’ for rapid, sensitive and quantitative monitoring of transduction pathway activation. These lentiviruses express a luminescent or fluorescent reporter under a pathway specific promoter or under a minimal promoter with embedded multiple tandem repeats incorporating pathway specific transcription factor binding motif. The pathway null control lentivirus has the minimal promoter without any signal pathway’s response elements inside the promoter. These lentiviruses also express an antibiotic selection marker or another fluorescent marker under a constitutive RSV promoter which serve as the internal normalisation control or as a convenient monitoring method for virus transduction efficiency. Options include androgen and oestrogen receptors, JNK, NF-?B, Notch and Wnt signalling pathways.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark
Aug 28 2024 Phnom Penh, Cambodia
Sep 04 2024 Chiba, Tokyo, Japan
Sep 04 2024 University of Warwick, Coventry, UK